Metabolic Research

Retatrutide
Triple-receptor agonist studied in preclinical and clinical literature for energy balance and metabolic homeostasis.
10 mg20 mg30 mg40 mg
View details →
Investigational GLP-1/GIP dual-receptor agonist analog
Dual-incretin analog studied in glucose homeostasis and energy-partitioning research models.
For laboratory research use only. Not for human, veterinary, diagnostic, cosmetic, or therapeutic use. Not evaluated by the FDA.